Buys R J, Abramson D H, Ellsworth R M, Haik B
Arch Ophthalmol. 1983 Aug;101(8):1206-8. doi: 10.1001/archopht.1983.01040020208007.
An analysis of 31 eyes of 30 patients who had been treated with cobalt plaques for retinoblastoma disclosed that a type I radiation regression pattern developed in 15 patients; type II, in one patient, and type III, in five patients. Nine patients had a regression pattern characterized by complete destruction of the tumor, the surrounding choroid, and all of the vessels in the area into which the plaque was inserted. This resulting white scar, corresponding to the sclerae only, was classified as a type IV radiation regression pattern. There was no evidence of tumor recurrence in patients with type IV regression patterns, with an average follow-up of 6.5 years, after receiving cobalt plaque therapy. Twenty-nine of these 30 patients had been unsuccessfully treated with at least one other modality (ie, light coagulation, cryotherapy, external beam radiation, or chemotherapy).
对30例接受钴板治疗视网膜母细胞瘤的患者的31只眼睛进行分析后发现,15例患者出现I型放射消退模式;1例患者出现II型,5例患者出现III型。9例患者的消退模式表现为肿瘤、周围脉络膜以及钴板植入区域内所有血管完全破坏。由此产生的仅与巩膜相对应的白色瘢痕被归类为IV型放射消退模式。在接受钴板治疗后,IV型消退模式的患者平均随访6.5年,无肿瘤复发迹象。这30例患者中有29例至少接受过一种其他治疗方式(即光凝、冷冻疗法、外照射放疗或化疗)但未成功。